A Multicenter Phase 1 Trial Evaluating the Safety and Preliminary Efficacy of Revumenib as Post-Transplant Maintenance After Allogeneic Hematopoietic Cell Transplant in Patients with KMT2A-Rearranged or NPM1-Mutated Acute Leukemia

Abstract | Dec 6, 2025

Author

Ball BJ, et al.

Congress

American Society of Hematology Annual Meeting 2025

Orlando, Florida | Dec 6 – 9, 2025